首页> 美国卫生研究院文献>Acta Myologica >Integrated care of muscular dystrophiesin Italy. Part 1. Pharmacological treatmentand rehabilitative interventions
【2h】

Integrated care of muscular dystrophiesin Italy. Part 1. Pharmacological treatmentand rehabilitative interventions

机译:肌营养不良的综合护理在意大利。第1部分。药物治疗和康复干预

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This paper describes the pharmacological therapies and rehabilitative interventions received by 502 patients with Muscular Dystrophies, evaluated in relation to patient's socio-demographic and clinical variables, and geographical areas.Data were collected by the MD-Socio-Demographic and Clinical Schedule (MD-SC-CS) and by the Family Problems Questionnaire (FPQ).The most part of the enrolled patients were in drug treatment. The number of the medications increased in relation to patient's age, disability degree and duration of illness and was higher among patients with Duchenne Muscular Dystrophy (DMD) compared with Becker (BMD) or Limb-Girdle Muscular Dystrophies (LGMD). Steroids (deflazacort or prednisone) were the drug most frequently used, followed by cardiologic and bone metabolism drugs. In general, patients using steroids were younger and had a shorter duration of illness; patients using cardiac drugs and dietary supplements were older and had a longer duration of illness.Rehabilitative interventions were provided to about 70% (351/502) of patients, mainly DMD. Of these, physiotherapy was the more frequent treatment (96.6%) and was prevalently performed in rehabilitative centres (about 70% of patients) and at home in only 30%. Hydrokinetic-therapy was practiced by 6.8% of patients. Respiratory rehabilitation was provided to 47.0% of patients (165/351) and assisted mechanical ventilaventilation to 13.1% (46). The amount of rehabilitative interventions increased in relation to the patient's age, level of disability and duration of illness.Compared to Central and Northern Italy, in Southern Italy there was a higher attention to cardiological impairment as shown by a higher number of patients receiving heart drugs.No statistically significant differences concerning the possibility to have access to rehabilitative interventions were noted among the three geographical areas. However, patient living in Southern Italy tend to receive rehabilitation more often at home.
机译:本文介绍了502例肌营养不良患者接受的药物治疗和康复干预措施,并根据患者的社会人口统计学和临床​​变量以及地理区域进行了评估。数据通过MD-社会人口统计学和临床​​时间表(MD-SC)收集-CS)和家庭问题问卷(FPQ)。大部分入选患者接受药物治疗。与贝克尔(BMD)或肢带肌肉萎缩症(LGMD)相比,药物的数量与患者的年龄,残疾程度和病程有关,并且在杜兴氏肌肉营养不良(DMD)患者中更高。类固醇(去黄酮或泼尼松)是最常用的药物,其次是心脏病和骨代谢药物。一般而言,使用类固醇的患者较年轻,病程较短。使用心脏药物和膳食补充剂的患者年龄较大且病程较长。约70%(351/502)的患者(主要是DMD)接受了康复干预。其中,物理疗法是更常见的治疗方法(96.6%),并且普遍在康复中心(约70%的患者)中进行,而在家中只有30%。 6.8%的患者进行了水动力疗法。 47.0%的患者进行了呼吸康复(165/351),辅助机械通气达到了13.1%(46)。与患者的年龄,残疾水平和疾病持续时间有关的康复干预措施的数量有所增加。与意大利中部和北部相比,意大利南部对心脏功能障碍的关注度更高,这表明接受心脏药物治疗的患者数量更多在这三个地理区域之间,没有关于获得康复干预措施可能性的统计上显着差异。但是,居住在意大利南部的患者倾向于在家中更经常地接受康复治疗。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号